Alignment Healthcare Reports Strong Q4 and Full-Year 2024 Results, Achieves First Positive Adjusted EBITDA Year

ALHC
November 02, 2025

Alignment Healthcare, Inc. reported robust financial results for its fourth quarter and full year ended December 31, 2024. For Q4 2024, total revenue increased by 50.7% year-over-year to $701.2 million, driven by a 58.6% rise in health plan membership to 189,100.

The company achieved an adjusted gross profit of $87.5 million in Q4 2024, a 103.5% increase from the prior year, and reported positive adjusted EBITDA of $1.9 million, compared to a loss of $26.4 million in Q4 2023. The Medical Benefits Ratio improved to 87.5% from 90.7% year-over-year.

For the full year 2024, Alignment Healthcare generated $2.70 billion in total revenue, a 48.3% increase over 2023, and achieved its first full year of positive adjusted EBITDA profitability. This marks a significant milestone in the company's financial trajectory.

Looking ahead, the company provided full-year 2025 guidance, projecting revenue between $3.65 billion and $3.75 billion, adjusted gross profit between $420 million and $435 million, and adjusted EBITDA between $40 million and $50 million. This guidance reflects confidence in continued growth and margin expansion.

The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.